Page last updated: 2024-09-04

cyc 202 and wedelolactone

cyc 202 has been researched along with wedelolactone in 1 studies

Compound Research Comparison

Studies (cyc 202)	Trials (cyc 202)	Recent Studies (post-2010) (cyc 202)	Studies (wedelolactone)	Trials (wedelolactone)	Recent Studies (post-2010) (wedelolactone)
979	7	393	123	0	94

Protein Interaction Comparison

Protein	Taxonomy	wedelolactone (IC50)
Gamma-aminobutyric acid receptor subunit pi	Rattus norvegicus (Norway rat)	2.5
Telomere resolvase ResT	Borreliella burgdorferi B31	8.67
Polyunsaturated fatty acid 5-lipoxygenase	Homo sapiens (human)	2.5
Glucose-6-phosphate 1-dehydrogenase	Homo sapiens (human)	5.18
Gamma-aminobutyric acid receptor subunit beta-1	Rattus norvegicus (Norway rat)	2.5
Carbonyl reductase [NADPH] 1	Homo sapiens (human)	3.78
Gamma-aminobutyric acid receptor subunit delta	Rattus norvegicus (Norway rat)	2.5
Gamma-aminobutyric acid receptor subunit gamma-2	Rattus norvegicus (Norway rat)	2.5
Gamma-aminobutyric acid receptor subunit alpha-5	Rattus norvegicus (Norway rat)	2.5
Gamma-aminobutyric acid receptor subunit alpha-3	Rattus norvegicus (Norway rat)	2.5
Gamma-aminobutyric acid receptor subunit gamma-1	Rattus norvegicus (Norway rat)	2.5
Gamma-aminobutyric acid receptor subunit alpha-2	Rattus norvegicus (Norway rat)	2.5
Gamma-aminobutyric acid receptor subunit alpha-4	Rattus norvegicus (Norway rat)	2.5
Gamma-aminobutyric acid receptor subunit gamma-3	Rattus norvegicus (Norway rat)	2.5
Gamma-aminobutyric acid receptor subunit alpha-6	Rattus norvegicus (Norway rat)	2.5
Gamma-aminobutyric acid receptor subunit alpha-1	Rattus norvegicus (Norway rat)	2.5
Gamma-aminobutyric acid receptor subunit beta-3	Rattus norvegicus (Norway rat)	2.5
Gamma-aminobutyric acid receptor subunit beta-2	Rattus norvegicus (Norway rat)	2.5
GABA theta subunit	Rattus norvegicus (Norway rat)	2.5
Gamma-aminobutyric acid receptor subunit epsilon	Rattus norvegicus (Norway rat)	2.5

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M	1

Other Studies

1 other study(ies) available for cyc 202 and wedelolactone

Article	Year
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51 Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases	2007

Article

Year

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.

Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007